Corbus Pharmaceuticals stock reaffirmed as Buy by H.C. Wainwright

H.C. Wainwright has reaffirmed its Buy rating on Evaxion Biotech, setting a target price of $16 for the stock. This endorsement highlights the firm's confidence in Evaxion's potential for growth and innovation in the biotech sector, which is crucial for investors looking for promising opportunities in healthcare.

H.C. Wainwright has reaffirmed its Buy rating on Agenus stock following encouraging data presented at the ESMO conference. This positive outlook is significant as it reflects confidence in Agenus' potential in the biotech sector, which could attract more investors and drive the stock price higher. The promising results from ESMO could pave the way for future developments and partnerships, making it an exciting time for both the company and its shareholders.

H.C. Wainwright has reaffirmed its Buy rating on Altimmune stock, highlighting the company's promising potential ahead of significant catalysts expected in the fourth quarter of 2025. This endorsement is crucial as it reflects confidence in Altimmune's growth prospects and could attract more investors, especially as the company approaches key developments that may impact its market performance.

Veritone's stock price target has been raised from $6 to $9 by H.C. Wainwright, signaling increased confidence in the company's future performance. This adjustment reflects the analysts' positive outlook on Veritone's growth potential and could attract more investors, boosting the stock's value.

Dakota Gold's director, O’Rourke, has sold shares worth $738,000, which raises questions about the company's future direction. While such transactions are common in the corporate world, they can signal shifts in confidence or strategy. Investors will be watching closely to see how this impacts Dakota Gold's performance and market perception.

RBB Bancorp has reported an impressive 8.7% increase in its quarterly net income, showcasing the company's strong financial performance. This growth is significant as it reflects the bank's effective strategies and resilience in a competitive market, which can boost investor confidence and potentially lead to further investments.

FRMO Corp's recent earnings call highlighted their innovative strategy in the crypto mining sector for Q1 2025. This approach not only showcases their commitment to staying ahead in the rapidly evolving digital currency landscape but also positions them for potential growth and profitability. Investors and stakeholders should pay attention, as this could signal a significant shift in the company's operations and market presence.

Rocket Lab's stock is experiencing a positive surge as the company prepares for its upcoming iQPS satellite launch. This event is significant not only for Rocket Lab but also for the satellite industry, as it showcases the company's growing capabilities and potential for future contracts. Investors are optimistic about the launch's success, which could lead to increased demand for Rocket Lab's services and further bolster its market position.

Dragonfly Energy has successfully restructured its term loan and issued Series B preferred stock, marking a significant step in its financial strategy. This move not only strengthens the company's balance sheet but also positions it for future growth in the energy sector. Investors are likely to view this positively, as it demonstrates the company's commitment to enhancing its capital structure and expanding its operations.

Bayview Acquisition Corp has made a significant $100,000 extension payment to its trust account, ensuring the continuation of its operations and potential future investments. This move is crucial as it reflects the company's commitment to maintaining its financial stability and pursuing strategic opportunities in the market.